|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Collaborations, milestones, and royalties | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Other income (expense): | |||||
| Interest income | |||||
| Interest expense | |||||
| Gain (loss) on marketable equity securities, net | |||||
| Asset impairment charges | |||||
| Other, net | |||||
| Impairment on equity securities | |||||
| Total other income (expense) | |||||
| Loss before income tax expense and noncontrolling interest | |||||
| Income tax expense | |||||
| Net loss including noncontrolling interest | |||||
| Net loss attributable to noncontrolling interest | |||||
| Net loss attributable to Xencor, Inc. | |||||
| Net unrealized loss on marketable securities available-for-sale | |||||
| Net loss per share attributable to Xencor, Inc. - basic (in dollars per share) | |||||
| Net loss per share attributable to Xencor, Inc. - diluted (in dollars per share) | |||||
| Weighted-average shares used in calculating net loss per share - basic (in shares) | |||||
| Weighted-average shares used in calculating net loss per share - diluted (in shares) | |||||
| Other comprehensive income (loss), net of tax: | |||||
| Net unrealized gain (loss) on marketable debt securities | |||||
| Comprehensive loss | |||||
| Less: comprehensive loss attributable to the noncontrolling interest | |||||
| Comprehensive loss attributable to Xencor, Inc. |
Loading...